Bo Baslund

Medicine & Life Sciences

1. Granulomatosis with Polyangiitis 100%
2. Antineutrophil Cytoplasmic Antibodies 44%
3. Vasculitis 39%
4. Rheumatoid Arthritis 32%
5. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 32%
6. Giant Cell Arteritis 24%
7. Systemic Vasculitis 19%
8. Myeloblastin 18%
9. Cohort Studies 18%
10. Peroxidase 14%
11. Takayasu Arteritis 13%
12. Population 13%
13. Methotrexate 13%
14. Incidence 13%
15. Mortality 12%
16. Multicenter Studies 11%
17. Therapeutics 11%
18. Denmark 11%
19. Tumor Necrosis Factor-alpha 10%
20. Tumor Necrosis Factor Inhibitors 10%
21. Confidence Intervals 10%
22. Antirheumatic Agents 10%
23. Sarcoidosis 9%
24. Rituximab 9%
25. Rheumatic Diseases 9%
26. Glucocorticoids 9%
27. Immunoassay 8%
28. Adrenal Insufficiency 8%
29. Inflammation 8%
30. Cyclophosphamide 8%
31. Adalimumab 7%
32. Morbidity 7%
33. Microscopic Polyangiitis 7%
34. NK Cell Lectin-Like Receptor Subfamily C 7%
35. Population Control 7%
36. ofatumumab 7%
37. Reduced Folate Carrier Protein 7%
38. Alleles 6%
39. Systemic Lupus Erythematosus 6%
40. tofacitinib 6%
41. T-Lymphocytes 6%
42. Biopsy 6%
43. Greenland 6%
44. Meta-Analysis 6%
45. HLA-DR4 Antigen 6%
46. tocilizumab 6%
47. Cross-Sectional Studies 6%
48. Rheumatology 6%
49. Mannose-Binding Lectin 6%
50. Sodium-Restricted Diet 5%